You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 6, June 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Clinical Renal Preservation by Cryoperfusion With an Albumin Perfusate

Renal Perfusion With Albumin

Richard L. Burleson, MD; David B. Jones, MD; Agheg M. Yenikomshian, MD; Claude Cornwall, MD; Christine DeVoe, RN; Jeanne DeRito, RN

Arch Surg. 1978;113(6):688-692.


Abstract

• Eighty-six human kidneys have been preserved by cryoperfusion with an albumin-based perfusate for five to 50 hours prior to transplantation. Sixty-three of the kidneys were transplanted. The overall immediate function rate was 72% and was 100% (34/34) for kidneys with no warm ischemic damage transplanted into recipients without hypotension or prior sensitivity. The overall actuarial one-month kidney survival rate was 87%, the three-month survival rate was 73%, and the one-year survival rate was 65%. No kidney was discarded because of poor perfusion. Perfusion data, including flow, diastolic pressure, perfusion time, and lactate concentration were not predictive of immediate renal function. Light, electron, and immunofluorescence microscopic study of biopsy specimens showed no evidence of perfusion or immunologic damage to the kidneys. Perfusion of transplantable kidneys with albumin provides reliable preservation for up to 50 hours without producing either structural or immunologic damage to the organ.

(Arch Surg 113:688-692, 1978)



Author Affiliations

From the Departments of Surgery (Drs Burleson and Yenikomshian, and Ms DeVoe and DeRito), Urology (Dr Burleson), and Pathology (Dr Jones), Upstate Medical Center, State University of New York, and the Department of Pathology (Dr Cornwall), Syracuse Veterans Administration Hospital, Syracuse, NY.


Footnotes

Accepted for publication Feb 10, 1978.

Read before the annual meeting of the Western Dialysis and Transplant Society, Los Angeles, Sept 17, 1977.

Reprint requests to Department of Surgery, Upstate Medical Center, 750 E Adams St, Syracuse, NY 13210 (Dr Burleson).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS
Iglesias et al.
Am. J. Physiol. Renal Physiol. 1999;277:F711-F722.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.